Literature DB >> 1336840

Effect of oxymetazoline nose drops on vascular permeability of the nasal mucosa in the rabbit after provocation with leukotriene B4.

M Bende1, P Hansell, M Intaglietta, K E Arfors.   

Abstract

The effects of oxymetazoline nose drops on the vascular permeability of the nasal mucosa in a provoked inflammatory reaction was studied in anesthetized rabbits. Vascular permeability (125I-albumin) was 53% higher in the leukotriene B4-provoked nostril (LTB4) compared with the vehicle-treated contralateral nostril (p < 0.05). The amount of secretions was, however, not different from the vehicle-treated side. The LTB4-induced increase in permeability was decreased by 22% when oxymetazoline was introduced (p < 0.05), and the amount of secretions was reduced by 22% (p < 0.01). The effect of oxymetazoline on the vascular permeability of the nasal mucosa can be attributed to a vascular constriction (decrease in blood flow) and/or a change in the permeability characteristics. The LTB4-induced increase in vascular permeability was not attenuated by the monoclonal antibody IB4 directed against the neutrophil adhesion complex CD11/CD18. The latter suggests that LTB4-induced vascular permeability does not require CD18-mediated neutrophil adherence in the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336840     DOI: 10.1159/000276313

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  3 in total

1.  LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects.

Authors:  Henrik Widegren; Morgan Andersson; Pierre Borgeat; Louis Flamand; Sebastian Johnston; Lennart Greiff
Journal:  Respir Med       Date:  2011-01-19       Impact factor: 3.415

Review 2.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

Review 3.  Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System.

Authors:  Manisha Pandey; Neha Jain; Jovita Kanoujia; Zahid Hussain; Bapi Gorain
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.